We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Global CT Market to Surpass USD 6 Billion by 2025 on Back of AI-Powered Imaging, Says Frost & Sullivan

By MedImaging International staff writers
Posted on 21 Oct 2021
Print article
Illustration
Illustration

The global computed tomography (CT) market is expected to register steady growth at a CAGR of 8.1% from USD 4.16 billion in 2020 to USD 6.14 billion by 2025, driven primarily by upgrading of existing scanners to high-end scanners, including artificial intelligence (AI)-powered CT scanners for cancer detection.

These are the latest findings of a recent analysis by Frost & Sullivan (Santa Clara, CA, USA).

An estimated 375 million CT procedures are carried out globally each year, increasing annually by 3-4%. The rapidly evolving needs of clinicians and radiologists, coupled with technology advancements such as photon-counting detector technology, machine learning, deep learning, and spectral imaging, have transformed the landscape of the global CT industry. The CT market worldwide is witnessing a gradual shift from low-end CT scanners to mid-high (64 slice) and high-end (128 slice and above) scanners, primarily due to CT technology innovations in reducing radiation dosage and expanding clinical applications in vascular, oncology, cardiac, and breast cancer imaging.

The trend of upgrading existing scanners to high-end scanners will present growth opportunities for market participants. For instance, mobile CT can increase overall CT use cases, widen the market for participants, and present a business opportunity for leading manufacturers with a broad CT portfolio. Additionally, with reimbursement approval from the current procedure terminology (CPT) and European regulations, cardiac imaging has taken a significant stride toward CT scanning. Moreover, a significant uptake of AI-based CT is anticipated by 2025 due to its efficiency and ability to handle large patient volumes. Regulatory approvals for these solutions are expected in the next one to two years. CT manufacturers should capitalize on the first-mover advantage by offering transparent and flexible pricing and partnering with start-ups.

“High-end CT purchases by university/academic and public hospitals in North America, Western Europe, and Japan are expected to propel the high-end CT segment revenue,” said Poornima Srinivasan, Healthcare & Life Sciences Consultant at Frost & Sullivan. “The 16- to 64-slice scanner shipments to diagnostic imaging centers in developing regions of LATAM, India and China are increasing and anticipated to experience moderate growth over the forecast period.”

“CT was at the forefront of combat against the COVID-19 pandemic as the majority of countries immediately installed CT for lung screening. Despite new purchases, the capacity of traditional unit shipments per year did not yield its full potential. As such, there is an expected pent-up demand for CT to fulfill needs-based requirements during the forecast period,” added Srinivasan.

Related Links:
Frost & Sullivan 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Digital Radiography Generator
meX+20BT lite
Portable Radiology System
DRAGON ELITE & CLASSIC
PACS Workstation
CHILI Web Viewer

Print article
Radcal

Channels

MRI

view channel
Image: Shorter scan to diagnose prostate cancer can increase availability and reduce cost (Photo courtesy of 123RF)

Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality

Prostate cancer ranks as the most prevalent cancer among men. Over the last decade, the introduction of MRI scans has significantly transformed the diagnosis process, marking the most substantial advancement... Read more

Nuclear Medicine

view channel
Image: The radiotheranostic platform employs a MUC16-targeting humanized antibody, huAR9.6 (Photo courtesy of MSK)

New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively

Ovarian cancer is the most lethal gynecological cancer, with less than a 30% five-year survival rate for those diagnosed in late stages. Despite surgery and platinum-based chemotherapy being the standard... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.